A decreased expression of CD200 and/or CD200R1 in the brain of Alzheimer’s disease20 and multiple sclerosis patients18,19 suggests that this inhibitory mechanism has been overloaded in these neurological disorders. The gene discussed is CD200; the disease is multiple sclerosis.